151 related articles for article (PubMed ID: 22080982)
1. The brave new world of antiplatelet therapy: seeking clarity in a world of increasing choice and complexity.
Price MJ
Rev Cardiovasc Med; 2011; 12 Suppl 1():S1-3. PubMed ID: 22080982
[No Abstract] [Full Text] [Related]
2. Antiplatelet medications: old and emerging therapies.
Stone WM; Naidu SG; Chapital A; Money SR
Ann Vasc Surg; 2010 Jan; 24(1):140-8. PubMed ID: 19619976
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
Angiolillo DJ; Suryadevara S; Capranzano P; Zenni MZ; Guzman LA; Bass TA
Catheter Cardiovasc Interv; 2009 Jan; 73(1):1-14. PubMed ID: 19089929
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
Tangelder MJ; van Hattum ES
Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897
[No Abstract] [Full Text] [Related]
5. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.
Cohen M
Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet agents in acute coronary syndromes.
Sakhuja R; Yeh RW; Bhatt DL
Curr Probl Cardiol; 2010 Mar; 35(3):123-70. PubMed ID: 20152547
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Paving the way for improved antiplatelet therapy.
Grove EL
Curr Pharm Des; 2012; 18(33):5195-6. PubMed ID: 22724421
[No Abstract] [Full Text] [Related]
8. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
Hobson A; Curzen N
Thromb Haemost; 2009 Jan; 101(1):23-30. PubMed ID: 19132185
[No Abstract] [Full Text] [Related]
9. Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy.
Tsang JL; Mendelsohn A; Tan MK; Hackam DG; Leiter LA; Fitchett D; Lin PJ; Grima E; Langer A; Goodman SG;
Am J Cardiol; 2008 Nov; 102(9):1142-5. PubMed ID: 18940280
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet agents: current drugs and future trends.
Messmore HL; Jeske WP; Wehrmacher W; Coyne E; Mobarhan S; Cho L; Leya FS; Moran JF
Hematol Oncol Clin North Am; 2005 Feb; 19(1):87-117, vi. PubMed ID: 15639110
[TBL] [Abstract][Full Text] [Related]
11. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
[TBL] [Abstract][Full Text] [Related]
12. Optimizing antiplatelet therapy following percutaneous coronary intervention: clinical pathways for platelet function testing.
Lassar TA; Simon DI; Croce K
Rev Cardiovasc Med; 2011; 12 Suppl 1():S23-33. PubMed ID: 22080984
[TBL] [Abstract][Full Text] [Related]
13. Should we monitor platelet function during antiplatelet therapy?
Hjemdahl P
Heart; 2008 Jun; 94(6):685-7. PubMed ID: 18480343
[No Abstract] [Full Text] [Related]
14. Dual antiplatelet therapy in the secondary prevention of atherothrombosis: need for new therapeutic approaches.
Sabatier B; Trinquart L; Emmerich J
Arch Cardiovasc Dis; 2010 Oct; 103(10):497-501. PubMed ID: 21130962
[No Abstract] [Full Text] [Related]
15. Monitoring oral antiplatelet therapy: is it justified?
Ang L; Mahmud E
Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):485-96. PubMed ID: 19124443
[TBL] [Abstract][Full Text] [Related]
16. Anti-platelet therapy: is it all over in peripheral artery disease?
Jaipersad AS; Silverman SH; Lip GY
Thromb Haemost; 2010 Apr; 103(4):689-91. PubMed ID: 20174749
[No Abstract] [Full Text] [Related]
17. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease.
Wang TY; Angiolillo DJ; Cushman M; Sabatine MS; Bray PF; Smyth SS; Dauerman HL; French PA; Becker RC
J Am Coll Cardiol; 2012 Mar; 59(10):891-900. PubMed ID: 22381424
[TBL] [Abstract][Full Text] [Related]
18. Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future.
Raju NC; Eikelboom JW; Hirsh J
Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):766-80. PubMed ID: 18957959
[TBL] [Abstract][Full Text] [Related]
19. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices.
Faxon DP
Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074
[TBL] [Abstract][Full Text] [Related]
20. Putting a stop to thrombi.
Palatnik A
Nursing; 2007; 37 Suppl Cardiac():2-6. PubMed ID: 18075484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
